Basel Medical Group closes registered direct offering, raises gross proceeds of US$7.98 million

Basel Medical Group closed a registered direct offering of 6,000,000 units for gross proceeds of US$7.98 million. Units priced at US$1.33 each, consisting of one ordinary share and one Common Warrant to buy one ordinary share. Net proceeds estimated at about US$7.28 million; funds earmarked for working capital, M&A, and general corporate purposes. Common Warrants exercisable immediately at 110% of the unit price; expire five years from issuance. Shares outstanding rose to 7,582,111; 6,000,000 Common Warrants outstanding following the transaction. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Basel Medical Group Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-046677), on October 13, 2026, and is solely responsible for the information contained therein. (